Ani pharmaceuticals announces the fda approval and launch of naproxen delayed-release tablets, usp

Princeton, n.j., july 02, 2024 (globe newswire) -- ani pharmaceuticals, inc. (ani or the company) (nasdaq: anip) today announced that it received u.s. food and drug administration (fda) approval for the abbreviated new drug application (anda) and launched naproxen delayed-release tablets, usp. ani's naproxen delayed-release tablets is the generic version of the reference listed drug (rld) ec-naprosyn®.
ANIP Ratings Summary
ANIP Quant Ranking